GB8602602D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB8602602D0
GB8602602D0 GB868602602A GB8602602A GB8602602D0 GB 8602602 D0 GB8602602 D0 GB 8602602D0 GB 868602602 A GB868602602 A GB 868602602A GB 8602602 A GB8602602 A GB 8602602A GB 8602602 D0 GB8602602 D0 GB 8602602D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB868602602A
Other versions
GB2170407A (en
GB2170407B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB8602602D0 publication Critical patent/GB8602602D0/en
Publication of GB2170407A publication Critical patent/GB2170407A/en
Priority to MYPI87002010A priority Critical patent/MY102906A/en
Application granted granted Critical
Publication of GB2170407B publication Critical patent/GB2170407B/en
Priority to MX9203583A priority patent/MX9203583A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08602602A 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions Expired GB2170407B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI87002010A MY102906A (en) 1986-02-03 1987-09-28 Pharmaceutical 9, 10-dihydro ergot alkaloid containing compositions
MX9203583A MX9203583A (en) 1985-02-05 1992-06-26 PHARMACEUTICAL COMPOSITION OF PROLONGED RELEASE BASED ON 9,10-DIHYDRO-ALCALOIDS.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions

Publications (3)

Publication Number Publication Date
GB8602602D0 true GB8602602D0 (en) 1986-03-12
GB2170407A GB2170407A (en) 1986-08-06
GB2170407B GB2170407B (en) 1988-10-26

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08602602A Expired GB2170407B (en) 1985-02-05 1986-02-03 Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions

Country Status (24)

Country Link
JP (1) JPS61183225A (en)
KR (1) KR920010388B1 (en)
AU (1) AU597570B2 (en)
BE (1) BE904152A (en)
CA (1) CA1263087A (en)
CH (1) CH667592A5 (en)
CY (1) CY1604A (en)
DE (1) DE3602577A1 (en)
DK (1) DK167138B1 (en)
ES (1) ES8800040A1 (en)
FR (1) FR2576787B1 (en)
GB (1) GB2170407B (en)
GR (1) GR860310B (en)
HK (1) HK57191A (en)
HU (1) HU195729B (en)
IE (1) IE59293B1 (en)
IT (1) IT1191255B (en)
LU (1) LU86289A1 (en)
NL (1) NL8600161A (en)
NZ (1) NZ215020A (en)
PH (1) PH23384A (en)
PT (1) PT81954B (en)
SE (1) SE8600496L (en)
SG (1) SG56191G (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111297815A (en) * 2020-04-29 2020-06-19 宝利化（南京）制药有限公司 Dihydroergotoxine mesylate sustained-release tablet and preparation method thereof

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (en) * 1987-02-18 1991-09-13 Pf Medicament DIHYDROERGOTAMINE (D.H.E.) TABLET OF THE HYDROPHILIC MATRIX TYPE AND MANUFACTURING METHOD THEREOF
SI8710406B (en) * 1987-03-11 1998-08-31 Lek Sustained release tablets on the basis of high molecular weight hydroxypropylmethylcellulose and a process for their manufacture
EP1235574B1 (en) * 1999-12-03 2005-02-02 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
EP1282412B1 (en) * 2000-05-12 2008-01-16 Meracol Corporation Limited Treating irritable bowel syndrome or disease
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
ES2298237T3 (en) * 2000-05-12 2008-05-16 Meracol Corporation Limited CETIL MIRISTATO AND CETIL PALMITATO FOR THE TREATMENT OF ECZEMA AND / OR SORIASIS.
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (en) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch ORAL ADMINISTRATIVE FORMS
CH649300A5 (en) * 1981-08-07 1985-05-15 Sandoz Ag ERGOPEPTIN DERIVATIVES, THEIR PRODUCTION AND USE.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (en) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach MOTHER CORNAL CALOIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (en) * 1983-06-22 1985-01-10 Shionogi & Co Ltd Pharmaceutical preparation of pinacidil of long acting type
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111297815A (en) * 2020-04-29 2020-06-19 宝利化（南京）制药有限公司 Dihydroergotoxine mesylate sustained-release tablet and preparation method thereof
CN111297815B (en) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 Dihydroergotoxine mesylate sustained-release tablet and preparation method thereof

Also Published As

Publication number Publication date
IT8647620A0 (en) 1986-02-05
DK52086D0 (en) 1986-02-03
IE860291L (en) 1986-08-05
SG56191G (en) 1991-08-23
GB2170407A (en) 1986-08-06
KR920010388B1 (en) 1992-11-27
PT81954B (en) 1988-07-01
PH23384A (en) 1989-07-26
IT1191255B (en) 1988-02-24
CA1263087A (en) 1989-11-21
LU86289A1 (en) 1986-09-02
FR2576787B1 (en) 1990-01-12
HK57191A (en) 1991-08-02
GB2170407B (en) 1988-10-26
FR2576787A1 (en) 1986-08-08
DE3602577A1 (en) 1986-08-28
HUT41984A (en) 1987-06-29
NL8600161A (en) 1986-09-01
AU597570B2 (en) 1990-06-07
CY1604A (en) 1992-04-03
ES8800040A1 (en) 1987-10-16
KR860006265A (en) 1986-09-09
DK52086A (en) 1986-08-06
SE8600496L (en) 1986-08-06
ES551635A0 (en) 1987-10-16
PT81954A (en) 1986-03-01
BE904152A (en) 1986-08-04
NZ215020A (en) 1989-07-27
IE59293B1 (en) 1994-02-09
AU5294286A (en) 1986-08-14
JPS61183225A (en) 1986-08-15
CH667592A5 (en) 1988-10-31
SE8600496D0 (en) 1986-02-04
GR860310B (en) 1986-05-27
DK167138B1 (en) 1993-09-06
HU195729B (en) 1988-07-28

Similar Documents

Publication Publication Date Title
GB8626808D0 (en) Pharmaceutical compositions
GB8524001D0 (en) Pharmaceutical composition
GB2174904B (en) Vasculoprotecting pharmaceutical compositions
GB8602787D0 (en) Pharmaceutical composition
GB8602788D0 (en) Pharmaceutical composition
GB8621577D0 (en) Pharmaceutical compositions
GB8530796D0 (en) Pharmaceutical composition
GB2171600B (en) Pharmaceutical compositions
GB8602625D0 (en) Pharmaceutical compositions
GB8618249D0 (en) Pharmaceutical compositions
GB8607906D0 (en) Pharmaceutical compositions
GB8618820D0 (en) Pharmaceutical compositions
GB8515170D0 (en) Pharmaceutical compositions
GB8602602D0 (en) Pharmaceutical compositions
GB8607848D0 (en) Pharmaceutical compositions
GB8618590D0 (en) Pharmaceutical compositions
GB2182561B (en) Pharmaceutical compositions
GB8610970D0 (en) Pharmaceutical compositions
GB8523531D0 (en) Pharmaceutical compositions
GB8522327D0 (en) Pharmaceutical compositions
GB8602601D0 (en) Pharmaceutical compositions
GB8618589D0 (en) Pharmaceutical compositions
GB8502887D0 (en) Pharmaceutical compositions
GB8608310D0 (en) Pharmaceutical compositions
GB8608309D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940203